Previous 10 | Next 10 |
Factors Driving Medical Robotic Growth Medical robotics is an emerging sector that has established a solid foundation and continues to grow. According to the Journal of Minimal Access Surgery , "the era of robots in surgery commenced in 1994 when the first AESOP (voice controlled camera hol...
LONDON , Sept. 5, 2019 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced the launch of its EVOS WRIST Plating System at the American Society for Surgery of the Hand (ASSH) Annual Meeting in Las Vegas, Nevada . EVOS WRIST ...
Our previous article on Zimmer Biomet ( ZBH ) was bullish . In short, we considered that the cheap valuation did reflect company-specific issues but was not structural. Indeed, the implants industry benefits from structural growth drivers such as an ageing population or a high prevalence of o...
Editor's note: Seeking Alpha is proud to welcome Carolina Doc as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Carolina Doc is a...
Smith & Nephew PLC (SNN) Q2 2019 Earnings Conference Call July 31, 2019, 03:30 ET Company Participants Namal Nawana - CEO Simon Fraser - President, Advanced Wound Management Graham Baker - CFO Conference Call Participants Patrick Wood - Bank of America Merrill Lynch D...
The following slide deck was published by Smith & Nephew plc in conjunction with their 2019 Q2 earnings Read more ...
Smith & Nephew ( SNN ) 1H results : Revenues: $2,485M (+1.8%); Orthopaedics: $1,098M (+0.5%); Sports Medicine & ENT: $747M (+2.5%); Advanced Wound Management: $640M (+3.4%). More news on: Smith & Nephew plc, Healthcare stocks news, Earnings news and commentary, Read more ....
Nancy Zambell , editor of Wall Street's Best Investments , chose Smith & Nephew plc ( SNN ) as her top conservative investment idea for 2019. The stock rose 16.5% in the first half of the year. Here's her latest update on the healthcare firm. The low beta for Smith &...
LONDON , July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs), one of the most com...
Editor's note: Seeking Alpha is proud to welcome FIN Capital Management LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » BAC...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...